Viemed Healthcare Inc Financials
This page shows Viemed Healthcare Inc (VMD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Viemed Healthcare Inc has an operating margin of 8.0%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 40/100, indicating healthy but not exceptional operating efficiency. This is up from 7.8% the prior year.
Viemed Healthcare Inc's revenue surged 22.5% year-over-year to $224.3M, reflecting rapid business expansion. This strong growth earns a score of 93/100.
Viemed Healthcare Inc carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Viemed Healthcare Inc's current ratio of 1.42 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.
While Viemed Healthcare Inc generated $39.1M in operating cash flow, capex of $37.8M consumed most of it, leaving $1.3M in free cash flow. This results in a low score of 3/100, reflecting heavy capital investment rather than weak cash generation.
Viemed Healthcare Inc's ROE of 8.6% shows moderate profitability relative to equity, earning a score of 34/100. This is down from 9.0% the prior year.
Viemed Healthcare Inc scores 6.73, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($314.8M) relative to total liabilities ($43.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Viemed Healthcare Inc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Viemed Healthcare Inc generates $3.47 in operating cash flow ($39.1M OCF vs $11.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Viemed Healthcare Inc generated $224.3M in revenue in fiscal year 2024. This represents an increase of 22.5% from the prior year.
Viemed Healthcare Inc's EBITDA was $43.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.6% from the prior year.
Viemed Healthcare Inc generated $1.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 93.1% from the prior year.
Viemed Healthcare Inc reported $11.3M in net income in fiscal year 2024. This represents an increase of 10.0% from the prior year.
Viemed Healthcare Inc earned $0.28 per diluted share (EPS) in fiscal year 2024. This represents an increase of 12.0% from the prior year.
Viemed Healthcare Inc held $17.5M in cash against $3.6M in long-term debt as of fiscal year 2024.
Viemed Healthcare Inc had 39M shares outstanding in fiscal year 2024. This represents an increase of 1.0% from the prior year.
Viemed Healthcare Inc's gross margin was 59.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 2.2 percentage points from the prior year.
Viemed Healthcare Inc's operating margin was 8.0% in fiscal year 2024, reflecting core business profitability. This is up 0.2 percentage points from the prior year.
Viemed Healthcare Inc's net profit margin was 5.0% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.
Viemed Healthcare Inc's ROE was 8.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the prior year.
Viemed Healthcare Inc invested $3.1M in research and development in fiscal year 2024. This represents an increase of 10.3% from the prior year.
Viemed Healthcare Inc spent $0 on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
Viemed Healthcare Inc invested $37.8M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 44.8% from the prior year.
VMD Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.9M+14.0% | $63.1M+6.6% | $59.1M-2.6% | $60.7M+10.4% | $55.0M+8.6% | $50.6M-0.3% | $50.7M+2.7% | $49.4M |
| Cost of Revenue | $30.6M+16.1% | $26.3M+1.8% | $25.9M+5.3% | $24.6M+11.3% | $22.1M+6.2% | $20.8M+11.6% | $18.6M-1.1% | $18.8M |
| Gross Profit | $41.3M+12.6% | $36.7M+10.4% | $33.3M-7.9% | $36.1M+9.9% | $32.9M+10.4% | $29.8M-7.2% | $32.1M+5.1% | $30.6M |
| R&D Expenses | $775K-8.5% | $847K+6.3% | $797K-0.7% | $803K+5.9% | $758K+1.1% | $750K+15.2% | $651K+9.8% | $593K |
| SG&A Expenses | $31.9M+10.8% | $28.8M+1.3% | $28.4M+0.8% | $28.2M+6.4% | $26.5M+6.8% | $24.8M+3.8% | $23.9M+1.1% | $23.7M |
| Operating Income | $5.6M+10.7% | $5.1M+32.6% | $3.8M-40.5% | $6.5M+78.4% | $3.6M+64.1% | $2.2M-58.3% | $5.3M+25.7% | $4.2M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $1.5M-10.4% | $1.7M+79.9% | $952K-49.4% | $1.9M+144.9% | $768K+48.3% | $518K-67.6% | $1.6M+21.1% | $1.3M |
| Net Income | $3.5M+11.3% | $3.2M+20.3% | $2.6M-39.2% | $4.3M+194.0% | $1.5M-8.4% | $1.6M-53.9% | $3.5M+19.1% | $2.9M |
| EPS (Diluted) | $0.09+12.5% | $0.08+33.3% | $0.06-40.0% | $0.10+150.0% | $0.040.0% | $0.04-50.0% | $0.08+14.3% | $0.07 |
VMD Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $202.4M+9.6% | $184.6M+3.7% | $178.1M+0.6% | $177.1M+8.0% | $163.9M+5.9% | $154.9M0.0% | $154.9M+3.7% | $149.4M |
| Current Assets | $50.0M-9.6% | $55.3M+12.6% | $49.1M-7.1% | $52.9M+17.6% | $45.0M+16.5% | $38.6M+0.7% | $38.4M+7.0% | $35.9M |
| Cash & Equivalents | $11.1M-44.4% | $20.0M+97.0% | $10.2M-42.1% | $17.5M+99.2% | $8.8M+20.5% | $7.3M-43.1% | $12.8M+27.4% | $10.1M |
| Inventory | $5.3M+21.9% | $4.3M-4.1% | $4.5M+4.4% | $4.3M-2.4% | $4.4M+1.7% | $4.3M-6.0% | $4.6M-0.9% | $4.7M |
| Accounts Receivable | $27.4M+3.3% | $26.5M-0.9% | $26.8M+7.5% | $24.9M-8.0% | $27.1M+10.6% | $24.5M+32.7% | $18.5M+2.9% | $17.9M |
| Goodwill | $58.5M+77.2% | $33.0M0.0% | $33.0M0.0% | $33.0M0.0% | $33.0M+10.8% | $29.8M0.0% | $29.8M+0.2% | $29.7M |
| Total Liabilities | $66.9M+55.6% | $43.0M+4.0% | $41.3M-5.6% | $43.8M+2.3% | $42.8M+10.8% | $38.6M-5.8% | $41.0M+1.0% | $40.6M |
| Current Liabilities | $44.2M+18.6% | $37.3M+5.0% | $35.5M-4.9% | $37.3M+18.6% | $31.5M+4.5% | $30.1M-6.2% | $32.1M+1.8% | $31.6M |
| Long-Term Debt | $19.6M+465.2% | $3.5M-1.8% | $3.5M-1.6% | $3.6M-58.8% | $8.7M+47.6% | $5.9M-1.6% | $6.0M-25.9% | $8.1M |
| Total Equity | $133.6M-4.4% | $139.7M+3.7% | $134.8M+2.6% | $131.4M+10.1% | $119.4M+2.7% | $116.3M+2.1% | $113.9M+4.7% | $108.8M |
| Retained Earnings | $97.3M+3.6% | $93.8M+3.4% | $90.7M+1.2% | $89.7M+9.9% | $81.6M+1.8% | $80.1M+0.8% | $79.5M+4.6% | $76.0M |
VMD Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.4M+49.9% | $12.3M+329.4% | $2.9M-81.0% | $15.0M+47.2% | $10.2M+766.6% | $1.2M-91.2% | $13.3M-3.8% | $13.8M |
| Capital Expenditures | $7.6M-6.1% | $8.1M-47.5% | $15.5M+30.9% | $11.8M+32.4% | $8.9M+48.8% | $6.0M-24.3% | $7.9M+7.2% | $7.4M |
| Free Cash Flow | $10.7M+160.1% | $4.1M+132.7% | -$12.6M-499.9% | $3.2M+153.0% | $1.2M+125.8% | -$4.8M-190.3% | $5.4M-16.5% | $6.4M |
| Investing Cash Flow | -$32.3M-1770.1% | -$1.7M+79.8% | -$8.5M+7.3% | -$9.2M+17.6% | -$11.2M-108.1% | -$5.4M+28.4% | -$7.5M+11.9% | -$8.5M |
| Financing Cash Flow | $5.0M+850.7% | -$671K+60.6% | -$1.7M-521.8% | $404K-83.7% | $2.5M+285.3% | -$1.3M+55.8% | -$3.0M+44.4% | -$5.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $11.6M | N/A | N/A | $0 | N/A | N/A | $0 | $0 |
VMD Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.5%-0.8pp | 58.3%+2.0pp | 56.3%-3.3pp | 59.5%-0.3pp | 59.8%+0.9pp | 58.9%-4.4pp | 63.3%+1.4pp | 61.9% |
| Operating Margin | 7.8%-0.2pp | 8.1%+1.6pp | 6.5%-4.1pp | 10.6%+4.1pp | 6.6%+2.2pp | 4.4%-6.1pp | 10.4%+1.9pp | 8.5% |
| Net Margin | 4.9%-0.1pp | 5.0%+0.6pp | 4.4%-2.7pp | 7.1%+4.4pp | 2.7%-0.5pp | 3.2%-3.7pp | 6.9%+0.9pp | 5.9% |
| Return on Equity | 2.6%+0.4pp | 2.3%+0.3pp | 1.9%-1.3pp | 3.3%+2.1pp | 1.2%-0.1pp | 1.4%-1.7pp | 3.0%+0.4pp | 2.7% |
| Return on Assets | 1.7%+0.0pp | 1.7%+0.2pp | 1.5%-1.0pp | 2.4%+1.5pp | 0.9%-0.1pp | 1.0%-1.2pp | 2.2%+0.3pp | 1.9% |
| Current Ratio | 1.13-0.4 | 1.48+0.1 | 1.38-0.0 | 1.42-0.0 | 1.43+0.1 | 1.28+0.1 | 1.19+0.1 | 1.14 |
| Debt-to-Equity | 0.15+0.1 | 0.020.0 | 0.030.0 | 0.03-0.0 | 0.07+0.0 | 0.050.0 | 0.05-0.0 | 0.07 |
| FCF Margin | 14.9%+8.4pp | 6.5%+27.9pp | -21.4%-26.6pp | 5.2%+2.9pp | 2.3%+11.8pp | -9.6%-20.1pp | 10.5%-2.4pp | 13.0% |
Similar Companies
Frequently Asked Questions
What is Viemed Healthcare Inc's annual revenue?
Viemed Healthcare Inc (VMD) reported $224.3M in total revenue for fiscal year 2024. This represents a 22.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Viemed Healthcare Inc's revenue growing?
Viemed Healthcare Inc (VMD) revenue grew by 22.5% year-over-year, from $183.0M to $224.3M in fiscal year 2024.
Is Viemed Healthcare Inc profitable?
Yes, Viemed Healthcare Inc (VMD) reported a net income of $11.3M in fiscal year 2024, with a net profit margin of 5.0%.
What is Viemed Healthcare Inc's earnings per share (EPS)?
Viemed Healthcare Inc (VMD) reported diluted earnings per share of $0.28 for fiscal year 2024. This represents a 12.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Viemed Healthcare Inc's EBITDA?
Viemed Healthcare Inc (VMD) had EBITDA of $43.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Viemed Healthcare Inc have?
As of fiscal year 2024, Viemed Healthcare Inc (VMD) had $17.5M in cash and equivalents against $3.6M in long-term debt.
What is Viemed Healthcare Inc's gross margin?
Viemed Healthcare Inc (VMD) had a gross margin of 59.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Viemed Healthcare Inc's operating margin?
Viemed Healthcare Inc (VMD) had an operating margin of 8.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Viemed Healthcare Inc's net profit margin?
Viemed Healthcare Inc (VMD) had a net profit margin of 5.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Viemed Healthcare Inc's return on equity (ROE)?
Viemed Healthcare Inc (VMD) has a return on equity of 8.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Viemed Healthcare Inc's free cash flow?
Viemed Healthcare Inc (VMD) generated $1.3M in free cash flow during fiscal year 2024. This represents a -93.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Viemed Healthcare Inc's operating cash flow?
Viemed Healthcare Inc (VMD) generated $39.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Viemed Healthcare Inc's total assets?
Viemed Healthcare Inc (VMD) had $177.1M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Viemed Healthcare Inc's capital expenditures?
Viemed Healthcare Inc (VMD) invested $37.8M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Viemed Healthcare Inc spend on research and development?
Viemed Healthcare Inc (VMD) invested $3.1M in research and development during fiscal year 2024.
How many shares does Viemed Healthcare Inc have outstanding?
Viemed Healthcare Inc (VMD) had 39M shares outstanding as of fiscal year 2024.
What is Viemed Healthcare Inc's current ratio?
Viemed Healthcare Inc (VMD) had a current ratio of 1.42 as of fiscal year 2024, which is considered adequate.
What is Viemed Healthcare Inc's debt-to-equity ratio?
Viemed Healthcare Inc (VMD) had a debt-to-equity ratio of 0.03 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Viemed Healthcare Inc's return on assets (ROA)?
Viemed Healthcare Inc (VMD) had a return on assets of 6.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Viemed Healthcare Inc's Altman Z-Score?
Viemed Healthcare Inc (VMD) has an Altman Z-Score of 6.73, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Viemed Healthcare Inc's Piotroski F-Score?
Viemed Healthcare Inc (VMD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Viemed Healthcare Inc's earnings high quality?
Viemed Healthcare Inc (VMD) has an earnings quality ratio of 3.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Viemed Healthcare Inc?
Viemed Healthcare Inc (VMD) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.